Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-31

Clinical Trial Update: MelaViD: A Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients [Phase 3]

View source ↗

Summary

Phase 3 trial investigating vitamin D supplementation after melanoma surgery was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: European Institute of Oncology | Conditions: Melanoma | Phase 3 | Status: TERMINATED